XML 19 R10.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities    
Net income $ 5,485 $ 7,290
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 358 391
Deferred income taxes 266 51
Accretion of discount on purchased loans (57) (121)
Amortization of CDI 79 90
Stock option compensation expense 66 46
Net recoveries on investment securities (8) (5)
Change in fair value of investments in equity securities 9 3
Amortization (accretion) of discounts and premiums on securities 101 (27)
Gain on sales of OREO and other repossessed assets, net 0 (21)
Gain on sales of loans, net (663) (2,002)
Loans originated for sale (22,379) (48,199)
Proceeds from sales of loans 22,559 43,839
Amortization of loan servicing rights 299 257
Valuation recovery (allowance) on loan servicing rights, net (119) 236
BOLI net earnings (154) (149)
Decrease in deferred loan origination fees (604) (987)
Net change in accrued interest receivable and other assets, and other liabilities and accrued expenses (978) 162
Net cash provided by operating activities 4,260 854
Cash flows from investing activities    
Net decrease in CDs held for investment 3,834 15,916
Purchase of investment securities held to maturity (48,486) 0
Purchase of investment securities available for sale 0 (10,267)
Proceeds from maturities and prepayments of investment securities held to maturity 2,995 3,444
Proceeds from maturities and prepayments of investment securities available for sale 6,502 2,360
Decrease (increase) in loans receivable, net (24,892) 7,674
Additions to premises and equipment (99) (109)
Proceeds from sales of OREO and other repossessed assets 0 803
Net cash (used in) provided by investing activities (60,146) 19,821
Cash flows from financing activities    
Net increase in deposits 36,076 16,710
Proceeds from exercise of stock options 130 96
Repurchase of common stock (433) (58)
Payment of dividends (1,755) (1,662)
Net cash provided by financing activities 34,018 15,086
Net increase (decrease) in cash and cash equivalents (21,868) 35,761
Cash and cash equivalents, at beginning of period 580,196 [1] 314,452
Cash and cash equivalents, at end of period 558,328 350,213
Supplemental disclosure of cash flow information    
Interest paid 656 980
Supplemental disclosure of non-cash investing activities    
Other comprehensive loss related to investment securities $ (17) $ (17)
[1] Derived from audited consolidated financial statements.